Here's a glimpse of the company's performance and key highlights:
âœ”ï¸ PI reported consolidated solid revenue growth of 31% YoY in 2QFY23, led by both CSM/Domestic businesses on the back of strong volume growth of 25%/31%, respectively
✔ï¸It aims to commercialize seven new molecules in the CSM
business and launch seven new products in the domestic industry in FY23.
âœ”ï¸ It has levers in place to sustain the near-term growth momentum, led by:
• Sustained growth momentum in the CSM business, driven by a strong order book, the rising pace of commercialization of new molecules, and sales of the ramp-up in existing molecules,
• Product launches in the domestic market, thus providing earnings visibility.
Would you be investing in PI Industries Ltd. Limited? Do let us know in the comments 💬 section.
⬇ï¸Download the 👇 apps now!
MO Investor app: http://ow.ly/huk250LqplcResearch360 app: http://ow.ly/Cup350Lqplf🔗 Disclaimer: http://ow.ly/63nS50Lqpleâ–¶ï¸ Share this with your investing buddy.
.
🔖 Save this post for future reference.
.
â˜‘ï¸ Follow us for well-researched stock performance and key highlights.
#MotilalOswal #CompanySpotlight #PIIndustriesLtd #experttips #chooserightstocks #investmentadvice #stockmarket #stockrecommendations #stockratings #stockanalysis #fundamentalanalysis #technicalanalysis #technicalreserach #marketanalysis #expertadvice #MotilalOswal #CompanySpotlight #PIIndustriesLtd #experttips #chooserightstocks #investmentadvice #stockmarket #stockrecommendations #stockratings #stockanalysis #fundamentalanalysis #technicalanalysis #technicalreserach #marketanalysis #expertadvice
Posted On: 26 Dec 2022 9:00 PM